Skip to content

Total Equity at other companies

Baxter International logo
Baxter InternationalBAX
$6.04B-14.7%
Boston Scientific logo
Boston ScientificBSX
$25.86B+16.4%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$1.63B+13.9%
Medtronic logo
MedtronicMDT
$49.46B+3.0%
Abbott logo
AbbottABT
$52.06B+6.7%
Cytokinetics logo
CytokineticsCYTK
-$826.57M-210%

Other financials

Income statement

See full
Revenue$199.4M+25.7%
Gross profit$141.4M+29.4%
Operating income-$16.2M+50.3%
Net income-$13.9M+54.6%
EPS (diluted)-$0.43+55.7%

Balance sheet

See full
Cash & equivalents$248.5M-35.2%
Total debt$79.0M-10.5%
Total assets$1.0B+8.7%

Cash flow

See full
Operating cash flow-$26.2M-232%
CapEx$6.9M-26.7%
Free cash flow-$33.1M-91.1%

Valuation

See full
Market cap$3.62B+16.0%

Profitability

See full
Gross margin71%+1.6pp
Operating margin-5.5%-2.2pp
Net margin-7.3%-3.1pp
FCF margin2.4%

Returns & leverage

See full
Return on equity-53.1%-17.4pp
Debt / equity0.5×-0.5×
Current ratio5.2×-0.5×

Where this comes from

Reported directly by iRhythm Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: iRhythm Holdings, Inc. ’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about iRhythm Holdings, Inc. 's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is iRhythm Holdings, Inc. 's total equity?
iRhythm Holdings, Inc. (IRTC) reported total equity of $161.21M in Q1 2026.
How has iRhythm Holdings, Inc. 's total equity changed year-over-year?
iRhythm Holdings, Inc. 's total equity increased by 86.0% year-over-year, from $86.67M to $161.21M.
What is the long-term trend for iRhythm Holdings, Inc. 's total equity?
Over 5 years (2020 to 2025), iRhythm Holdings, Inc. 's total equity has grown at a -14.9% compound annual growth rate (CAGR), from $341.61M to $152.75M.
What does total equity mean?
Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.